Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Journal of Hepatology|September 4, 2009
Nonstructural 5A protein activates beta-catenin signaling cascades: implication of hepatitis C virus-induced liver pathogenesisChul-Yong Park, Soo-Ho Choi, Sang-Min Kang, et al.
Experimental & Molecular Medicine|April 14, 2018
Wnt signal activation induces midbrain specification through direct binding of the beta-catenin/TCF4 complex to the EN1 promoter in human pluripotent stem cellsJi Young Kim, Jae Souk Lee, Hyun Sub Hwang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
Targeted inversion and reversion of the blood coagulation factor 8 gene in human iPS cells using TALENsChul-Yong Park, Jungeun Kim, Jiyeon Kweon, et al.
Bioorganic & Medicinal Chemistry Letters|September 14, 2011
Synthesis and biological evaluation of 1-substituted-3-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitorsCheng Hua Jin, Maddeboina Krishnaiah, Domalapally Sreenu, et al.
Stem Cell Reports|May 5, 2015
PSA-NCAM-negative neural crest cells emerging during neural induction of pluripotent stem cells cause mesodermal tumors and unwanted graftsDongjin R Lee, Jeong-Eun Yoo, Jae Souk Lee, et al.
Experimental & Molecular Medicine|January 6, 2025
Long-term correction of hemophilia A via integration of a functionally enhanced FVIII gene into the AAVS1 locus by nickase in patient-derived iPSCsDo-Hun Kim, Sang-Hwi Choi, Jin Jea Sung, et al.
European Journal of Medicinal Chemistry|June 24, 2011
Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitorsCheng Hua Jin, Domalapally Sreenu, Maddeboina Krishnaiah, et al.
Experimental & Molecular Medicine|December 20, 2011
Disease-specific induced pluripotent stem cells: a platform for human disease modeling and drug discoveryJiho Jang, Jeong-Eun Yoo, Jeong-Ah Lee, et al.
Biomaterials|February 26, 2022
Therapeutic correction of hemophilia A using 2D endothelial cells and multicellular 3D organoids derived from CRISPR/Cas9-engineered patient iPSCsJeong Sang Son, Chul-Yong Park, Gyunggyu Lee, et al.
Cell Stem Cell|December 12, 2023
Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's diseaseSanghyun Park, Chan Wook Park, Jang Hyeon Eom, et al.
Pageof 4